TY - JOUR
T1 - Phenylalanine 193 in Extracellular Loop 2 of the β2-Adrenergic Receptor Coordinates β-Arrestin Interaction
AU - Ippolito, Michael
AU - De Pascali, Francesco
AU - Inoue, Asuka
AU - Benovic, Jeffrey L.
N1 - Funding Information:
Research reported in this publication was supported by the National Institutes of Health awards R35GM122541 (J.L.B.), R01HL136219 (J.L.B.), P01HL114471 (J.L.B.), T32GM100836 (M.I.), and F31HL139104 (M.I.), and used the MetaOmics Shared Resource at Sidney Kimmel Cancer Center at Jefferson Health supported by National Institutes of Health award P30CA056036. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. A.I. was funded by KAKENHI 21H04791 from The Japan Society for the Promotion of Science (JSPS); the PRIME 20gm5910013, the LEAP JP20gm0010004 and the BINDS JP20am0101095 from the Japan Agency for Medical Research and Development (AMED), and the Uehara Memorial Foundation. No author has a conflict with the contents of this article. dx.doi.org/10.1124/molpharm.121.000332.
Publisher Copyright:
© 2022 by The American Society.
PY - 2022/2/1
Y1 - 2022/2/1
N2 - G protein-coupled receptors (GPCRs) transduce a diverse variety of extracellular stimuli into intracellular signaling. These receptors are the most clinically productive drug targets at present. Despite decades of research on the signaling consequences of molecule-receptor interactions, conformational components of receptor-effector interactions remain incompletely described. The b2-adrenergic receptor (β2AR) is a prototypical and extensively studied GPCR that can provide insight into this aspect of GPCR signaling thanks to robust structural data and rich pharmacopeia. Using bioluminescence resonance energy transfer -based biosensors, second messenger assays, and biochemical techniques, we characterize the properties of b2AR-F193A. This single point mutation in extracellular loop 2 of the b2AR is sufficient to intrinsically bias the b2AR away from b-arrestin interaction and demonstrates altered regulatory outcomes downstream of this functional selectivity. This study highlights the importance of extracellular control of intracellular response to stimuli and suggests a previously undescribed role for the extracellular loops of the receptor and the extracellular pocket formed by transmembrane domains 2, 3, and 7 in GPCR regulation that may contribute to biased signaling at GPCRs.
AB - G protein-coupled receptors (GPCRs) transduce a diverse variety of extracellular stimuli into intracellular signaling. These receptors are the most clinically productive drug targets at present. Despite decades of research on the signaling consequences of molecule-receptor interactions, conformational components of receptor-effector interactions remain incompletely described. The b2-adrenergic receptor (β2AR) is a prototypical and extensively studied GPCR that can provide insight into this aspect of GPCR signaling thanks to robust structural data and rich pharmacopeia. Using bioluminescence resonance energy transfer -based biosensors, second messenger assays, and biochemical techniques, we characterize the properties of b2AR-F193A. This single point mutation in extracellular loop 2 of the b2AR is sufficient to intrinsically bias the b2AR away from b-arrestin interaction and demonstrates altered regulatory outcomes downstream of this functional selectivity. This study highlights the importance of extracellular control of intracellular response to stimuli and suggests a previously undescribed role for the extracellular loops of the receptor and the extracellular pocket formed by transmembrane domains 2, 3, and 7 in GPCR regulation that may contribute to biased signaling at GPCRs.
UR - http://www.scopus.com/inward/record.url?scp=85123812904&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123812904&partnerID=8YFLogxK
U2 - 10.1124/molpharm.121.000332
DO - 10.1124/molpharm.121.000332
M3 - Article
C2 - 34853152
AN - SCOPUS:85123812904
SN - 0026-895X
VL - 101
SP - 87
EP - 94
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 2
ER -